
Sign up to save your podcasts
Or
Check out our free downloads at nascentmc.com:
See the full write ups for today's episodes at nascentmc.com/podcast
In this week's New FDA Approval's podcast episode, Dr. Emma Hitt Nichols discusses the latest FDA approvals from August 7, 2023 – August 11, 2023. Please check back every Monday morning so that you can stay up to date.
Here are the highlights:
· The FDA has approved Akeega, a combination of niraparib (PARP inhibitor) and abiraterone acetate (anti-androgen), as the first orally administered treatment for BRCA-positive metastatic castration-resistant prostate cancer. The approval was based on the MAGNITUDE study showing improved progression-free survival with the addition of niraparib.
· Talvey (talquetamab-tgvs), a bispecific T-cell engaging antibody, has received accelerated approval for patients with relapsed or refractory multiple myeloma who have undergone multiple previous therapies.
· Izervay (avacincaptad pegol intravitreal solution), a complement C5 inhibitor, has gained FDA approval for use in geographic atrophy related to age-related macular degeneration, and showed a significant reduction in disease progression.
· Boston Scientific's POLARx Cryoablation System has been approved for treating paroxysmal atrial fibrillation, demonstrating effectiveness in reducing paroxysmal atrial arrhythmias in the FROZEN-AF IDE clinical trial.
The full writeups are available here: https://nascentmc.com/podcast/
Intro and outro music
Garden Of Love by Pk jazz Collective
5
44 ratings
Check out our free downloads at nascentmc.com:
See the full write ups for today's episodes at nascentmc.com/podcast
In this week's New FDA Approval's podcast episode, Dr. Emma Hitt Nichols discusses the latest FDA approvals from August 7, 2023 – August 11, 2023. Please check back every Monday morning so that you can stay up to date.
Here are the highlights:
· The FDA has approved Akeega, a combination of niraparib (PARP inhibitor) and abiraterone acetate (anti-androgen), as the first orally administered treatment for BRCA-positive metastatic castration-resistant prostate cancer. The approval was based on the MAGNITUDE study showing improved progression-free survival with the addition of niraparib.
· Talvey (talquetamab-tgvs), a bispecific T-cell engaging antibody, has received accelerated approval for patients with relapsed or refractory multiple myeloma who have undergone multiple previous therapies.
· Izervay (avacincaptad pegol intravitreal solution), a complement C5 inhibitor, has gained FDA approval for use in geographic atrophy related to age-related macular degeneration, and showed a significant reduction in disease progression.
· Boston Scientific's POLARx Cryoablation System has been approved for treating paroxysmal atrial fibrillation, demonstrating effectiveness in reducing paroxysmal atrial arrhythmias in the FROZEN-AF IDE clinical trial.
The full writeups are available here: https://nascentmc.com/podcast/
Intro and outro music
Garden Of Love by Pk jazz Collective
129 Listeners
325 Listeners
493 Listeners
652 Listeners
3,332 Listeners
90 Listeners
122 Listeners
28 Listeners
716 Listeners
318 Listeners
559 Listeners
88 Listeners
17 Listeners
15 Listeners
3 Listeners